In Part 2, Brad and Andrew dive into the key evidence-based interventions for cardiometabolic syndrome.
Dietary modification is an important preventative strategy used to reduce the incidence of dyslipidaemia; a major risk factor for coronary heart disease (CHD) and when managed properly, has also been shown to reduce the incidence of cardiovascular disease (CVD)
Magnesium is famed for its widespread health benefits, with one particular form, magnesium orotate, thoroughly researched as an unequivocal therapeutic for cardiovascular health. Magnesium orotate’s application in this area may reduce the risk of various conditions ranging from mitral valve prolapse (MVP) to tachycardia and hypertension, according to a recent meta-analysis.
Hyperhomocysteinaemia may arise from genetic defects of several enzymes involved in homocysteine metabolism including MTHFR, MTR and CBS.
Prolonged periods of stress are putting Australians at risk of hypocortisolism and therefore at risk of a number of health conditions, one such condition being osteoporosis.
In today's podcast, Dr Ross Walker reveals how to decisively treat heart disease using diet and lifestyle measures, with judicious use of nutraceuticals and warranted medications for demonstrated disease progression.
Studies indicate that low levels of the thyroid hormone fT3 are associated with poorer outcomes in patients with cardiovascular disease and may be a useful risk analysis tool in this population.
In today's podcast, Dr Mark Houston covers the relevance of patient genetics in understanding the progression of disease, as well as the modifiable risk factors and key methods of assessment based on his clinical experience.